Human gut hormone profiles in patients with short bowel syndrome
- PMID: 1563315
- DOI: 10.1007/BF01296430
Human gut hormone profiles in patients with short bowel syndrome
Abstract
We have studied gut hormone profiles in a small number of patients on treatment with home parenteral nutrition following near-total enterectomy who had no evidence of inflammatory bowel disease and who were otherwise healthy. These and age- and sex-matched controls had gut hormone profiles measured after an overnight fast and a standard test meal. Circulating pancreatic glucagon concentrations and profiles were the same in both groups as were the neurotensin and VIP. Peptide YY (PYY) concentrations and profiles were markedly raised in the short bowel group. It is suggested that the normal glucagon responses reflect the integrity of the remaining duodenum and pancreas. Circulating neurotensin and VIP originate largely from outside the bowel and so the removal of the gut source does not significantly affect their profiles. Enteroglucagon and PYY are secreted from terminal ileum and colon in response to unabsorbed food residues. The elevated circulating levels and profiles are consistent with those observed by others in patients with jejunoileal bypass or major resections in whom unabsorbed nutrients reach the colon.
Similar articles
-
Elevated plasma glucagon-like peptide 1 and 2 concentrations in ileum resected short bowel patients with a preserved colon.Gut. 2000 Sep;47(3):370-6. doi: 10.1136/gut.47.3.370. Gut. 2000. PMID: 10940274 Free PMC article.
-
Time course of adaptive regulatory peptide changes following massive small bowel resection in the dog.Dig Dis Sci. 1996 Jun;41(6):1194-203. doi: 10.1007/BF02088237. Dig Dis Sci. 1996. PMID: 8654152
-
Impaired meal stimulated glucagon-like peptide 2 response in ileal resected short bowel patients with intestinal failure.Gut. 1999 Oct;45(4):559-63. doi: 10.1136/gut.45.4.559. Gut. 1999. PMID: 10486365 Free PMC article.
-
Peptide YY(1-36) and peptide YY(3-36): Part II. Changes after gastrointestinal surgery and bariatric surgery.Obes Surg. 2006 Jun;16(6):795-803. doi: 10.1381/096089206777346619. Obes Surg. 2006. PMID: 16756746 Review.
-
"Gut-feeling" or evidence-based approaches in the evaluation and treatment of human short-bowel syndrome.Pediatr Surg Int. 2000;16(3):155-64. doi: 10.1007/s003830050713. Pediatr Surg Int. 2000. PMID: 10786972 Review.
Cited by
-
Peptide YY selectively stimulates expression of the colonocytic phenotype.J Gastrointest Surg. 1997 Nov-Dec;1(6):561-8. doi: 10.1016/s1091-255x(97)80073-x. J Gastrointest Surg. 1997. PMID: 9834392
-
Gastrointestinal hormones in short bowel syndrome. Peptide YY may be the 'colonic brake' to gastric emptying.Gut. 1996 Aug;39(2):267-72. doi: 10.1136/gut.39.2.267. Gut. 1996. PMID: 8977342 Free PMC article.
-
Gut hormones as potential new targets for appetite regulation and the treatment of obesity.Drugs. 2008;68(2):147-63. doi: 10.2165/00003495-200868020-00002. Drugs. 2008. PMID: 18197723 Review.
-
Ileal release of glucagon-like peptide-1 (GLP-1). Association with inhibition of gastric acid secretion in humans.Dig Dis Sci. 1995 May;40(5):1074-82. doi: 10.1007/BF02064202. Dig Dis Sci. 1995. PMID: 7729267
-
Distal small bowel hormones: correlation with fasting antroduodenal motility and gastric emptying.Dig Dis Sci. 1998 May;43(5):945-52. doi: 10.1023/a:1018806129102. Dig Dis Sci. 1998. PMID: 9590405